-
Je něco špatně v tomto záznamu ?
Synthesis of lucifensin by native chemical ligation and characteristics of its isomer having different disulfide bridge pattern
S. Stanchev, Z. Zawada, L. Monincová, L. Bednárová, J. Slaninová, V. Fučík, V. Čeřovský,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
24920043
DOI
10.1002/psc.2663
Knihovny.cz E-zdroje
- MeSH
- antiinfekční látky * chemická syntéza chemie farmakologie MeSH
- defensiny * chemická syntéza chemie farmakologie MeSH
- grampozitivní bakterie růst a vývoj MeSH
- kationické antimikrobiální peptidy * chemická syntéza chemie farmakologie MeSH
- sekundární struktura proteinů MeSH
- Publikační typ
- časopisecké články MeSH
The antimicrobial 40-amino-acid-peptide lucifensin was synthesized by native chemical ligation (NCL) using N-acylbenzimidazolinone (Nbz) as a linker group. NCL is a method in which a peptide bond between two discreet peptide chains is created. This method has been applied to the synthesis of long peptides and proteins when solid-phase synthesis is imcompatible. Two models of ligation were developed: [15+25] Ala-Cys and [19+21] His-Cys. The [19+21] His-Cys method gives lower yield because of the lower stability of 18-peptide-His-Nbz-CONH2 peptide, as suggested by density functional theory calculation. Acetamidomethyl-deprotection and subsequent oxidation of the ligated linear lucifensin gave a mixture of lucifensin isomers, which differed in the location of their disulfide bridges only. The dominant isomer showed unnatural pairing of cysteines [C1-6], [C3-5], and [C2-4], which limits its ability to form α-helical structure. The activity of isomeric lucifensin toward Bacillus subtilis, Staphylococcus aureus, and Micrococcus luteus was lower than that of the natural lucifensin. The desired product native lucifensin was prepared from this isomer using a one-pot reduction with dithiotreitol and subsequent air oxidation in slightly alkaline medium.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15023337
- 003
- CZ-PrNML
- 005
- 20150731111534.0
- 007
- ta
- 008
- 150709s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/psc.2663 $2 doi
- 035 __
- $a (PubMed)24920043
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Stanchev, Stancho $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2, 16610, Prague, Czech Republic.
- 245 10
- $a Synthesis of lucifensin by native chemical ligation and characteristics of its isomer having different disulfide bridge pattern / $c S. Stanchev, Z. Zawada, L. Monincová, L. Bednárová, J. Slaninová, V. Fučík, V. Čeřovský,
- 520 9_
- $a The antimicrobial 40-amino-acid-peptide lucifensin was synthesized by native chemical ligation (NCL) using N-acylbenzimidazolinone (Nbz) as a linker group. NCL is a method in which a peptide bond between two discreet peptide chains is created. This method has been applied to the synthesis of long peptides and proteins when solid-phase synthesis is imcompatible. Two models of ligation were developed: [15+25] Ala-Cys and [19+21] His-Cys. The [19+21] His-Cys method gives lower yield because of the lower stability of 18-peptide-His-Nbz-CONH2 peptide, as suggested by density functional theory calculation. Acetamidomethyl-deprotection and subsequent oxidation of the ligated linear lucifensin gave a mixture of lucifensin isomers, which differed in the location of their disulfide bridges only. The dominant isomer showed unnatural pairing of cysteines [C1-6], [C3-5], and [C2-4], which limits its ability to form α-helical structure. The activity of isomeric lucifensin toward Bacillus subtilis, Staphylococcus aureus, and Micrococcus luteus was lower than that of the natural lucifensin. The desired product native lucifensin was prepared from this isomer using a one-pot reduction with dithiotreitol and subsequent air oxidation in slightly alkaline medium.
- 650 12
- $a antiinfekční látky $x chemická syntéza $x chemie $x farmakologie $7 D000890
- 650 12
- $a kationické antimikrobiální peptidy $x chemická syntéza $x chemie $x farmakologie $7 D023181
- 650 12
- $a defensiny $x chemická syntéza $x chemie $x farmakologie $7 D023082
- 650 _2
- $a grampozitivní bakterie $x růst a vývoj $7 D006094
- 650 _2
- $a sekundární struktura proteinů $7 D017433
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zawada, Zbigniew
- 700 1_
- $a Monincová, Lenka
- 700 1_
- $a Bednárová, Lucie
- 700 1_
- $a Slaninová, Jiřina
- 700 1_
- $a Fučík, Vladimír
- 700 1_
- $a Čeřovský, Václav
- 773 0_
- $w MED00002886 $t Journal of peptide science an official publication of the European Peptide Society $x 1099-1387 $g Roč. 20, č. 9 (2014), s. 725-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24920043 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150731111620 $b ABA008
- 999 __
- $a ok $b bmc $g 1083675 $s 906330
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c 9 $d 725-35 $i 1099-1387 $m Journal of peptide science $n J Pept Sci $x MED00002886
- LZP __
- $a Pubmed-20150709